Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
about
MiR-1178 promotes the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells by targeting CHIP.Survival of patients with pancreatic cancer treated with varied modalities: A single-centre study.The art and science of radiation therapy for gastrointestinal cancers.Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
P2860
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
@ast
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
@en
type
label
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
@ast
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
@en
prefLabel
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
@ast
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
@en
P2093
P2860
P1476
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
@en
P2093
Drexell H Boggs
Kruti N Patel
Michael D Chuong
William F Regine
P2860
P304
P356
10.3978/J.ISSN.2078-6891.2014.025
P577
2014-06-01T00:00:00Z